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1. Introduction 
It is generally believed that, in most tissues, the con- 
trol of the glycolytic flux is regulated at the phospho- 
fructokinase (PFK) step and that the main effecters 
are ATP and citrate (inhibitors) and CAMP, AMP, Pi, 
F6P and FDP (activators) [l-5, see also 61. Although 
little doubt exists that these effecters act on the PFK 
of all tissues, lipogenic and non-lipogenic alike, it seems 
probable that some differences exist in their relative ef- 
fectiveness between tissues of different function. Thus, 
it is logical that in muscle, where glucose metabolism is 
largely directed to energy production, the main con- 
trol is vested in ATP and citrate as inhibitors and AMP 
as an activator. In a lipogenic tissue, such as liver, other 
considerations apply, namely the requirement for a high 
glycolytic flux to provide the acetyl-CoA for lipogenesis 
at a time when there is no necessity for an appreciable 
change in the activity of the tricarboxylic acid cycle. 
In this situation a logical case could be made for a con- 
trol system which is linked to the blood glucose. Such 
a system would act to permit a high flux rate in glycol- 
ysis when the blood glucose is high and the distribution 
of the acetyl-CoA so produced between oxidation and 
lipogenesis would then be regulated by the redox state 
of the nicotinamide nucleotides and the phosphoryla- 
tion state of the adenine nucleotides in the mitochon- 
dria. The present communication examines changes in 
the content of effector molecules in intact livers from 
rats in different dietary and hormonal conditions and, 
North-Holland Publishing Company - Amsterdam 
by a comparison of this in vivo data with the known 
kinetic properties of the enzyme, attempts to relate 
these to the specific requirements for control of the 
glycolytic flux in liver at PFK. It would appear that, 
in liver under these conditions, F6P is the most signi- 
ficant modulator of PFK activity, thus relating the 
activity of this enzyme to the rate of glucose phospho- 
rylation. The modification of the Ki for citrate by 
F6P [7] permits a rapid rate of glycolysis and lipo- 
genesis without feed-back inhibition by citrate. 
2. Methods 
2.1, Animals and treatments 
The nutritional and hormonal treatments used 
were such as to produce metabolic patterns where the 
carbon flux was mainly in the direction of gluconeo- 
genesis (i.e. starvation, starvation followed by refeeding 
a high fat diet or diabetes) or of glycolysis and tricar- 
boxylic acid cycle oxidation (i.e. starvation followed 
by refeeding a high carbohydrate diet or diabetic ani- 
mals treated with insulin). Details of the diets and 
treatments are as given by Novello, Gumaa and McLean 
[8] except that the rats were starved for 72 hr instead 
of 48 hr. Diabetic rats were not used until 3 weeks 
after the administration of alloxan and insulin treat- 
ment was for 3 days (2 I.U./day). The number of rats 
in these groups was not less than 6. 
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2.2. Assay procedures ing to reduce the activity of PFK. 
Measurements were made of the cell contents of the 
glycolytic and tricarboxylic acid cycle intermediates, 
using perchloric acid extracts of freeze-clamped livers 
prepared as described by Lagunas, McLean and Green- 
baum [9], by the procedures given in Gumaa and 
McLean [lo] or Lagunas, McLean and Greenbaum 
[9] . Carbon fluxes were also measured as described 
previously [9]. 
The intracellular distribution of citrate was calculated 
according to Williamson [ 111. 
3. Results and discussion 
Table 1 shows the cell content of some of the me- 
tabolites known to affect PFK together with an estim- 
ate of the flux of carbon through the glycolytic path- 
way as measured by the rate of production of i4C02 
from 3,4-‘4C-glucose. Although this latter may not be 
a complete measurement of glycolytic flux since it omits 
any formation of lactate, it does provide a reasonable 
approximation to the total flux. 
From the data provided in the table, there is no ob- 
vious correlation between the changes of flux rates and 
the tissue content of CAMP, AMP, Pi, FDP, NH:, total 
ATP, the ATP/ADP X Pi ratio (either total cell or cyto- 
plasmic) or of total cell citrate. It should be noted that, 
in their study of the effect of butylmalonate on gluco- 
neogenesis in perfused liver, Williamson, Anderson and 
Browning [ 121 also found changes in the activity of 
PFK which could not be accounted for by the observed 
changes in the content of effector molecules and as- 
cribed the effect to a redistribution of citrate between 
mitochondria and cytosol, although this was not actual- 
ly calculated. In the present case, we have calculated 
the cytosolic content of citrate (last column) by the 
procedure described by Williamson [ 1 l] and it is ap- 
parent that there is no systematic relationship between 
the cytoplasmic citrate and the activity of PFK, assum- 
ing that this enzyme is the rate-limiting step in glycolysis 
Similarly, Start and Newsholme [13, 141 also observed 
that the direction of change of the adenine nucleotides 
and citrate in starvation did not correspond to that ex- 
pected if they were effective agents in decreasing gly- 
colysis and increasing gluconeogenesis. Instead, they 
proposed that F6P may act as an important modulator 
of hepatic PFK activity, the fall of F6P in starvation act- 
In the present experiments, a good correlation 
(correlation coefficient = 0.85, 5% limit = 0.81) ap- 
pears to exist between flux rate and fructose-6-phos- 
phate content. Three points established by Passonneau 
and Lowry [7] concerning the properties of hepatic 
PFK are germane to an understanding of this correla- 
tion. First, that the inhibition of PFK by ATP can be 
largely reversed by AMP (0.3 mM) and Pi (10 mM) in 
combination. Second, that, in contrast to brain, the 
ATP inhibition of hepatic PFK is not reversed by levels 
of F6P ten times higher than those occurring in vivo. 
Third, that an increase in F6P concentration raises 
the Ki for citrate inhibition. This last point seems to 
be of paramount importance in a tissue such as liver 
where it is necessary to maintain a high glycolytic 
flux to provide the acetyl-CoA, reducing equivalents 
and ATP necessary for lipogenesis, which, as stated 
above, itself requires a high level of citrate both as a 
substrate for lipogenesis via the citrate cleavage enzyme 
and as an activator of acetyl-CoA carboxylase. An in- 
crease of ,F6P in conditions of increased glycolytic flux 
and higher lipid synthesis will, by raising the Ki for 
citrate, simultaneously release PFK from inhibition 
and allow substrate to be present for fatty acid syn- 
thesis in the same compartment. Conversely, in con- 
ditions of decreased glycolytic flux and lowered ac- 
tivity of the fatty acid synthesising system, F6P falls. 
This, in turn, will lower the Ki for the citrate inhibition 
of PFK and thus inhibit the enzyme without the neces- 
sity for any change in citrate concentration, or even 
in the presence of a lower cytoplasmic citrate con- 
tent. Passonneau and Lowry found that the value of 
the Ki for citrate inhibition in the presence of 0.08 
mM F6P (approximately the same level as found in 
the liver in the present experiments, which ranges 
from 0.036 mM to 0.09 mM) was 0.14 mM. The cal- 
culated value for the cytoplasmic citrate in the pre- 
sent experiments ranges from 0.18 mM to 0.31 mM, 
i.e. not far removed from the Ki found by Passon- 
neau and Lowry [7] . Atkinson [ 151 has emphasised 
that, to achieve maximum sensitivity and flexibility 
of control systems, it is essential that the concentra- 
tions of the substrates and effecters should approxi- 
mate closely to the K, values. The present data fit 
this requirement in a satisfactory manner. 
The question now arises as to the factors regulat- 
ing the F6P in the liver. It would be expected, by 
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definition of a control enzyme [16], that F6P should 
decrease in situations where there is an increased flux 
through PFK, whereas the opposite is true for the liver 
in the present experiments. In this context, the free 
permeability of the liver to glucose and the properties 
of glucokinase are of particular relevance. Liver gluco- 
kinase operates only at relatively high glucose concentra- 
tions (K, = lo-’ M) and is not subject to feedback in- 
hibition by G6P [ 171. Furthermore, both glucose and 
insulin are required for the maintenance and induction 
of this enzyme [ 181. These properties permit a rapid 
rate of glucose phosphorylation to occur in liver under 
conditions where there is a high portal blood glucose 
and insulin (i.e. in rats starved and refed a high carbo- 
hydrate diet or in diabetic rats treated with insulin) the 
resultant effect of which is to increase the steady state 
concentration of G6P and, because of the high activity 
of phosphoglucose isomerase, of F6P. Sillero, Sillero 
and Sols 1191 have shown, from experiments with 
diabetic rats given diets containing fructose, that gluco- 
kinase is unique among the glycolytic and gluconeo- 
genie enzymes in having an absolute requirement for 
insulin. 
The stimulation of PFK by the raised F6P may, in 
some instances, cause an increase of FDP, itself an ac- 
tivator of PFK. This is evident in the case of the starved 
rats refed a high carbohydrate diet. In other conditions, 
other mechanisms may assume a more important role. 
For instance, it has been reported [9] that, in the livers 
of rats treated with nicotinamide, the main control of 
PFK appeared to be vested in ATP and citrate and a 
typical cross-over was found in the metabolite profile. 
It is, perhaps, appropriate at this point to consider 
some of the properties of the enzymes involved in lipo- 
genesis with respect to citrate. Inspection of the.table 
shows that there is no correlation between cytoplasmic 
citrate and the rate of lipogenesis. However, there is no 
reason to believe that the levels of citrate present are not 
adequate to support the observed rates of fatty acid 
synthesis. The quoted K, for citrate cleavage enzyme 
is 5.8 X 10e4 M [20] while the calculated cytoplasmic 
content here is approximately 2 X 10V4 M. However, 
it is probable that the true substrate for the cleavage 
enzyme is the Mg2+-citrate complex and the K, for 
this is 1.62 X 10e6 M [21]. Further, it is probable that 
the K, for the activation of acetyl-CoA carboxylase by 
citrate of 0.05 M quoted by Waite and Wakil [22] is 
also too high. Fang and Lowenstein [23] have shown 
that the activation of the carboxylase is both time 
and concentration dependent and Gregolin et al. [24] 
have found an extraordinarily tight binding of citrate 
by the carboxylase (2-3 PM for chicken liver). Thus 
taking both of these observations into account, it is 
probable that the native enzyme in vivo is fully ac- 
tivated. It would therefore appear that the regulation 
of the citrate inhibition of hepatic PFK by F6P is the 
valve allowing greater glycolytic flux and lipogenesis 
without postulating changes in citrate distribution or 
concentration. 
Another point worth noting is that a parallel situa- 
tion holds for pyruvate kinase (PK) as for the relief 
by F6P of inhibition of PFK by citrate. A high cyto- 
plasmic ATP is required to drive the synthetic reac- 
tions of fatty acid synthesis and for glucose phospho- 
rylation, but is incompatible with a high activity of 
PK, a key enzyme in the supply of acetyl-CoA for 
fatty acid synthesis. Here again, the control is not 
by alteration of the ATP concentration, which could 
not be made to suit both enzyme systems without 
“compartmentation”, but rather by a modification 
of the kinetic properties of the key enzyme involved, 
in this case pyruvate kinase. It is also interesting that 
further coordination is achieved by the stimulation 
of fatty acid synthesis by fructose diphosphate [25] . 
Since this stimulation by fructose diphosphate is 
achieved by decreasing the K, of fatty acid syn- 
thetase for NADPH, it is clear that additional coordi- 
nation will be brought into play involving, in this in- 
stance, the pentose phosphate pathway for which 
there is clear evidence for rate-limitation by the supply 
of NADP + .
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